Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from ExaWizards Inc. ( (JP:4259) ).
ExaWizards Inc. has announced the commercialization of ‘LocoStep,’ an AI gait analysis medical application developed by its subsidiary, ExaMD Inc. This innovative app, which allows for easy and quick measurement of motor function using a smartphone or iPad, is expected to contribute significantly to addressing the challenges of Japan’s aging population. While the app is designed to support healthcare providers in managing patients at risk of declining motor function, its impact on the company’s sales for the current fiscal year is anticipated to be minimal.
More about ExaWizards Inc.
ExaWizards Inc. operates in the technology industry, focusing on developing AI-driven solutions to address social issues, particularly in the health and medical sectors. Its subsidiary, ExaMD Inc., specializes in creating products and services utilizing multimodal AI technology, with a focus on cognitive and motor functions, aiming to tackle challenges such as dementia.
Average Trading Volume: 1,583,009
Technical Sentiment Signal: Buy
Current Market Cap: Yen36.28B
Find detailed analytics on 4259 stock on TipRanks’ Stock Analysis page.